{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:12:32Z","timestamp":1790140352516,"version":"4.0.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/nrneurol.2011.176","type":"journal-article","created":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T16:41:44Z","timestamp":1320165704000},"page":"688-698","source":"Crossref","is-referenced-by-count":153,"title":["Longitudinal extensive transverse myelitis\u2014it's not all neuromyelitis optica"],"prefix":"10.1038","volume":"7","author":[{"given":"Corinna","family":"Trebst","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke Verena","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulus","family":"Rommer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazen","family":"Abu-Mugheisib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe K.","family":"Zettl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Stangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,1]]},"reference":[{"key":"BFnrneurol2011176_CR1","doi-asserted-by":"crossref","unstructured":"Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 59, 499\u2013505 (2002).","DOI":"10.1212\/WNL.59.4.499"},{"key":"BFnrneurol2011176_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1055\/s-2007-1019132","volume":"28","author":"A Jacob","year":"2008","unstructured":"Jacob, A. & Weinshenker, B. G. An approach to the diagnosis of acute transverse myelitis. Semin. Neurol. 28, 105\u2013120 (2008).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol2011176_CR3","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJMcp1001112","volume":"363","author":"EM Frohman","year":"2010","unstructured":"Frohman, E. M. & Wingerchuk, D. M. Clinical practice. Transverse myelitis. N. Engl. J. Med. 363, 564\u2013572 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2011176_CR4","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon, V. A. et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364, 2106\u20132112 (2004).","journal-title":"Lancet"},{"key":"BFnrneurol2011176_CR5","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F. & Weinshenker, B. G. Revised diagnostic criteria for neuromyelitis optica. Neurology 66, 1485\u20131489 (2006).","journal-title":"Neurology"},{"key":"BFnrneurol2011176_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1440-1673.2008.02017.x","volume":"52","author":"P Bou-Haidar","year":"2008","unstructured":"Bou-Haidar, P., Peduto, A. J. & Karunaratne, N. Differential diagnosis of T2 hyperintense spinal cord lesions: part A. J. Med. Imaging Radiat. Oncol. 52, 535\u2013543 (2008).","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"BFnrneurol2011176_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1754-9485.2009.02067.x","volume":"53","author":"P Bou-Haidar","year":"2009","unstructured":"Bou-Haidar, P., Peduto, A. J. & Karunaratne, N. Differential diagnosis of T2 hyperintense spinal cord lesions: part B. J. Med. Imaging Radiat. Oncol. 53, 152\u2013159 (2009).","journal-title":"J. Med. Imaging Radiat. Oncol."},{"key":"BFnrneurol2011176_CR8","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1067\/j.cpradiol.2009.05.004","volume":"39","author":"DD Do-Dai","year":"2010","unstructured":"Do-Dai, D. D., Brooks, M. K., Goldkamp, A., Erbay, S. & Bhadelia, R. A. Magnetic resonance imaging of intramedullary spinal cord lesions: a pictorial review. Curr. Probl. Diagn. Radiol. 39, 160\u2013185 (2010).","journal-title":"Curr. Probl. Diagn. Radiol."},{"key":"BFnrneurol2011176_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","volume":"306","author":"S Jarius","year":"2011","unstructured":"Jarius, S. et al. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures. J. Neurol. Sci. 306, 82\u201390 (2011).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2011176_CR10","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/archneur.63.3.390","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock, S. J. et al. Brain abnormalities in neuromyelitis optica. Arch. Neurol. 63, 390\u2013396 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011176_CR11","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1001\/archneur.63.7.964","volume":"63","author":"SJ Pittock","year":"2006","unstructured":"Pittock, S. J. et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch. Neurol. 63, 964\u2013968 (2006).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011176_CR12","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/01.nrl.0000250927.21903.f8","volume":"13","author":"DM Wingerchuk","year":"2007","unstructured":"Wingerchuk, D. M. Diagnosis and treatment of neuromyelitis optica. Neurologist 13, 2\u201311 (2007).","journal-title":"Neurologist"},{"key":"BFnrneurol2011176_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neurad.2008.12.008","volume":"36","author":"C Cassinotto","year":"2009","unstructured":"Cassinotto, C. et al. MRI of the spinal cord in neuromyelitis optica and recurrent longitudinal extensive myelitis. J. Neuroradiol. 36, 199\u2013205 (2009).","journal-title":"J. Neuroradiol."},{"key":"BFnrneurol2011176_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/ana.20770","volume":"59","author":"BG Weinshenker","year":"2006","unstructured":"Weinshenker, B. G. et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann. Neurol. 59, 566\u2013569 (2006).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2011176_CR15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello, M. et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 70, 2197\u20132200 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2011176_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/mus.21197","volume":"39","author":"A McKeon","year":"2009","unstructured":"McKeon, A. et al. Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve 39, 87\u201390 (2009).","journal-title":"Muscle Nerve"},{"key":"BFnrneurol2011176_CR17","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1002\/art.27337","volume":"62","author":"KP Wandinger","year":"2010","unstructured":"Wandinger, K. P. et al. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sj\u00f6gren's syndrome. Arthritis Rheum. 62, 1198\u20131200 (2010).","journal-title":"Arthritis Rheum."},{"key":"BFnrneurol2011176_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali, C. et al. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61, 554\u2013558 (2002).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneurol2011176_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande, S. et al. Neurologic manifestations in primary Sj\u00f6gren syndrome: a study of 82 patients. Medicine (Baltimore) 83, 280\u2013291 (2004).","journal-title":"Medicine (Baltimore)"},{"key":"BFnrneurol2011176_CR20","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1136\/ard.2010.130476","volume":"69","author":"GK Bertsias","year":"2010","unstructured":"Bertsias, G. K. et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann. Rheum. Dis. 69, 2074\u20132082 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"BFnrneurol2011176_CR21","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/art.30157","volume":"63","author":"J Luyendijk","year":"2011","unstructured":"Luyendijk, J. et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum. 63, 722\u2013732 (2011).","journal-title":"Arthritis Rheum."},{"key":"BFnrneurol2011176_CR22","doi-asserted-by":"publisher","unstructured":"Schulz, S. W. et al. Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases. Rheumatol. Int. http:\/\/dx.doi.org\/10.1007\/s00296-011-2053-1 .","DOI":"10.1007\/s00296-011-2053-1"},{"key":"BFnrneurol2011176_CR23","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/0961203307081846","volume":"16","author":"AC Heinlein","year":"2007","unstructured":"Heinlein, A. C. & Gertner, E. Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus. Lupus 16, 823\u2013826 (2007).","journal-title":"Lupus"},{"key":"BFnrneurol2011176_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jbspin.2009.12.006","volume":"77","author":"AR Mornas","year":"2010","unstructured":"Mornas, A. R., Thomas, T., Pallot, P. B., Chopin, F. & Raoux, D. Longitudinal myelitis in a patient with systemic lupus erythematosus. Joint Bone Spine 77, 181\u2013183 (2010).","journal-title":"Joint Bone Spine"},{"key":"BFnrneurol2011176_CR25","doi-asserted-by":"crossref","first-page":"56s","DOI":"10.1183\/09031936.01.18s320056","volume":"32","author":"U Costabel","year":"2001","unstructured":"Costabel, U. Sarcoidosis: clinical update. Eur. Respir. J. Suppl. 32, 56s\u201368s (2001).","journal-title":"Eur. Respir. J. Suppl."},{"key":"BFnrneurol2011176_CR26","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1001\/archneur.1985.04060080095022","volume":"42","author":"BJ Stern","year":"1985","unstructured":"Stern, B. J., Krumholz, A., Johns, C., Scott, P. & Nissim, J. Sarcoidosis and its neurological manifestations. Arch. Neurol. 42, 909\u2013917 (1985).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011176_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jns.2009.08.060","volume":"287","author":"S Bolat","year":"2009","unstructured":"Bolat, S., Berding, G., Dengler, R., Stangel, M. & Trebst, C. Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. J. Neurol. Sci. 287, 257\u2013259 (2009).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2011176_CR28","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s11926-008-0057-y","volume":"10","author":"KT Calamia","year":"2008","unstructured":"Calamia, K. T. & Kaklamanis, P. G. Beh\u00e7et's disease: recent advances in early diagnosis and effective treatment. Curr. Rheumatol. Rep. 10, 349\u2013355 (2008).","journal-title":"Curr. Rheumatol. Rep."},{"key":"BFnrneurol2011176_CR29","unstructured":"[No authors listed] Criteria for diagnosis of Beh\u00e7et's disease. International Study Group for Beh\u00e7et's Disease. Lancet 335, 1078\u20131080 (1990)."},{"key":"BFnrneurol2011176_CR30","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","volume":"122","author":"G Akman-Demir","year":"1999","unstructured":"Akman-Demir, G., Serdaroglu, P. & Tasci, B. Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group. Brain 122, 2171\u20132182 (1999).","journal-title":"Brain"},{"key":"BFnrneurol2011176_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.2169\/internalmedicine.49.2175","volume":"49","author":"J Fukae","year":"2010","unstructured":"Fukae, J. et al. Subacute longitudinal myelitis associated with Beh\u00e7et's disease. Intern. Med. 49, 343\u2013347 (2010).","journal-title":"Intern. Med."},{"key":"BFnrneurol2011176_CR32","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1111\/j.1468-1331.2007.01754.x","volume":"14","author":"N Yesilot","year":"2007","unstructured":"Yesilot, N. et al. Clinical characteristics and course of spinal cord involvement in Beh\u00e7et's disease. Eur. J. Neurol. 14, 729\u2013737 (2007).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011176_CR33","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1148\/radiology.195.3.7754002","volume":"195","author":"LM Tartaglino","year":"1995","unstructured":"Tartaglino, L. M. et al. Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters. Radiology 195, 725\u2013732 (1995).","journal-title":"Radiology"},{"key":"BFnrneurol2011176_CR34","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1136\/jnnp.2009.172973","volume":"81","author":"W Qiu","year":"2010","unstructured":"Qiu, W. et al. Longitudinally extensive myelopathy in Caucasians: a West Australian study of 26 cases from the Perth Demyelinating Diseases Database. J. Neurol. Neurosurg. Psychiatry 81, 209\u2013212 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011176_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1136\/jnnp.2007.133330","volume":"79","author":"S Jarius","year":"2008","unstructured":"Jarius, S. et al. Polyspecific, antiviral immune response distinguishes multiple sclerosis and neuromyelitis optica. J. Neurol. Neurosurg. Psychiatry 79, 1134\u20131136 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011176_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman, C. H. et al. Diagnostic criteria for multiple sclerosis: revisions to the McDonald criteria. Ann. Neurol. 69, 292\u2013302 (2011) (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2011176_CR37","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1212\/01.wnl.0000284600.80782.d5","volume":"70","author":"B Banwell","year":"2008","unstructured":"Banwell, B. et al. Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology 70, 344\u2013352 (2008).","journal-title":"Neurology"},{"key":"BFnrneurol2011176_CR38","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1055\/s-2007-1019130","volume":"28","author":"NP Young","year":"2008","unstructured":"Young, N. P., Weinshenker, B. G. & Lucchinetti, C. F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 28, 84\u201394 (2008).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol2011176_CR39","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-2002-36536","volume":"22","author":"JR Berger","year":"2002","unstructured":"Berger, J. R. & Sabet, A. Infectious myelopathies. Semin. Neurol. 22, 133\u2013142 (2002).","journal-title":"Semin. Neurol."},{"key":"BFnrneurol2011176_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jaut.2009.09.013","volume":"34","author":"J Sellner","year":"2010","unstructured":"Sellner, J., Hemmer, B. & Muhlau, M. The clinical spectrum and immunobiology of parainfectious neuromyelitis optica (Devic) syndromes. J. Autoimmun. 34, 371\u2013379 (2010).","journal-title":"J. Autoimmun."},{"key":"BFnrneurol2011176_CR41","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1080\/13550280701258431","volume":"13","author":"F Umehara","year":"2007","unstructured":"Umehara, F. et al. Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy. J. Neurovirol. 13, 260\u2013267 (2007).","journal-title":"J. Neurovirol."},{"key":"BFnrneurol2011176_CR42","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3109\/13550281003801493","volume":"16","author":"SR Delgado","year":"2010","unstructured":"Delgado, S. R., Sheremata, W. A., Brown, A. D. & McCarthy, M. Human T-lymphotropic virus type I or II (HTLV-I\/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports. J. Neurovirol. 16, 249\u2013253 (2010).","journal-title":"J. Neurovirol."},{"key":"BFnrneurol2011176_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1159\/000081864","volume":"52","author":"L Meurs","year":"2004","unstructured":"Meurs, L., Labeye, D., Declercq, I., Pieret, F. & Gille, M. Acute transverse myelitis as a main manifestation of early stage II neuroborreliosis in two patients. Eur. Neurol. 52, 186\u2013188 (2004).","journal-title":"Eur. Neurol."},{"key":"BFnrneurol2011176_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1212\/01.wnl.0000342460.07764.5c","volume":"72","author":"L Chilver-Stainer","year":"2009","unstructured":"Chilver-Stainer, L., Fischer, U., Hauf, M., Fux, C. A. & Sturzenegger, M. Syphilitic myelitis: rare, nonspecific, but treatable. Neurology 72, 673\u2013675 (2009).","journal-title":"Neurology"},{"key":"BFnrneurol2011176_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00415-003-0921-7","volume":"250","author":"S Kikuchi","year":"2003","unstructured":"Kikuchi, S., Shinpo, K., Niino, M. & Tashiro, K. Subacute syphilitic meningomyelitis with characteristic spinal MRI findings. J. Neurol. 250, 106\u2013107 (2003).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011176_CR46","first-page":"1646","volume":"26","author":"S Saleem","year":"2005","unstructured":"Saleem, S., Belal, A. I. & el Ghandour, N. M. Spinal cord schistosomiasis: MR imaging appearance with surgical and pathologic correlation. AJNR Am. J. Neuroradiol. 26, 1646\u20131654 (2005).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol2011176_CR47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.3174\/ajnr.A1864","volume":"31","author":"HS Seo","year":"2010","unstructured":"Seo, H. S. et al. Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review. AJNR Am. J. Neuroradiol. 31, 498\u2013503 (2010).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol2011176_CR48","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1212\/WNL.0b013e31821f468f","volume":"76","author":"EP Flanagan","year":"2011","unstructured":"Flanagan, E. P. et al. Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76, 2089\u20132095 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol2011176_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","volume":"78","author":"F Ducray","year":"2007","unstructured":"Ducray, F. et al. Devic's syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies. J. Neurol. Neurosurg. Psychiatry 78, 325\u2013327 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011176_CR50","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus, F. et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J. Neurol. Neurosurg. Psychiatry 75, 1135\u20131140 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"BFnrneurol2011176_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/01.wco.0000236615.59215.d3","volume":"19","author":"SJ Pittock","year":"2006","unstructured":"Pittock, S. J. & Lucchinetti, C. F. Inflammatory transverse myelitis: evolving concepts. Curr. Opin. Neurol. 19, 362\u2013368 (2006).","journal-title":"Curr. Opin. Neurol."},{"key":"BFnrneurol2011176_CR52","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1002\/ana.20529","volume":"58","author":"SJ Pittock","year":"2005","unstructured":"Pittock, S. J. et al. Amphiphysin autoimmunity: paraneoplastic accompaniments. Ann. Neurol. 58, 96\u2013107 (2005).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol2011176_CR53","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock, S. J. et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin. Proc. 81, 1207\u20131214 (2006).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrneurol2011176_CR54","doi-asserted-by":"publisher","first-page":"19-e3","DOI":"10.1111\/j.1468-1331.2010.03220.x","volume":"18","author":"MJ Titulaer","year":"2011","unstructured":"Titulaer, M. J. et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur. J. Neurol. 18, 19-e3 (2011).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011176_CR55","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1007\/s00330-009-1425-3","volume":"19","author":"W Krampla","year":"2009","unstructured":"Krampla, W. et al. Spinal cord lesions in patients with neuromyelitis optica: a retrospective long-term MRI follow-up study. Eur. Radiol. 19, 2535\u20132543 (2009).","journal-title":"Eur. Radiol."},{"key":"BFnrneurol2011176_CR56","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/j.1468-1331.2010.03200.x","volume":"18","author":"FJ Mateen","year":"2011","unstructured":"Mateen, F. J., Monrad, P. A., Hunderfund, A. N., Robertson, C. E. & Sorenson, E. J. Clinically suspected fibrocartilaginous embolism: clinical characteristics, treatments, and outcomes. Eur. J. Neurol. 18, 218\u2013225 (2011).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011176_CR57","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00330-004-2510-2","volume":"15","author":"T Krings","year":"2005","unstructured":"Krings, T., Mull, M., Gilsbach, J. M. & Thron, A. Spinal vascular malformations. Eur. Radiol. 15, 267\u2013278 (2005).","journal-title":"Eur. Radiol."},{"key":"BFnrneurol2011176_CR58","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3174\/ajnr.A0612","volume":"28","author":"M Mull","year":"2007","unstructured":"Mull, M. et al. Value and limitations of contrast-enhanced MR angiography in spinal arteriovenous malformations and dural arteriovenous fistulas. AJNR Am. J. Neuroradiol. 28, 1249\u20131258 (2007).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol2011176_CR59","first-page":"57","volume":"43","author":"UK Misra","year":"2003","unstructured":"Misra, U. K., Kalita, J. & Das, A. Vitamin B12 deficiency neurological syndromes: a clinical, MRI and electrodiagnostic study. Electromyogr. Clin. Neurophysiol. 43, 57\u201364 (2003).","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"BFnrneurol2011176_CR60","first-page":"2112","volume":"27","author":"BP Goodman","year":"2006","unstructured":"Goodman, B. P., Chong, B. W., Patel, A. C., Fletcher, G. P. & Smith, B. E. Copper deficiency myeloneuropathy resembling B12 deficiency: partial resolution of MR imaging findings with copper supplementation. AJNR Am. J. Neuroradiol. 27, 2112\u20132114 (2006).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"BFnrneurol2011176_CR61","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00415-010-5511-x","volume":"257","author":"SR Jaiser","year":"2010","unstructured":"Jaiser, S. R. & Winston, G. P. Copper deficiency myelopathy. J. Neurol. 257, 869\u2013881 (2010).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011176_CR62","first-page":"1134","volume":"66","author":"A McKeon","year":"2009","unstructured":"McKeon, A. et al. Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch. Neurol. 66, 1134\u20131138 (2009).","journal-title":"Arch. Neurol."},{"key":"BFnrneurol2011176_CR63","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jocn.2010.05.030","volume":"18","author":"KC Wang","year":"2011","unstructured":"Wang, K. C., Wang, S. J., Lee, C. L., Chen, S. Y. & Tsai, C. P. The rescue effect of plasma exchange for neuromyelitis optica. J. Clin. Neurosci. 18, 43\u201346 (2011).","journal-title":"J. Clin. Neurosci."},{"key":"BFnrneurol2011176_CR64","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1111\/j.1468-1331.2010.03066.x","volume":"17","author":"J Sellner","year":"2010","unstructured":"Sellner, J. et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur. J. Neurol. 17, 1019\u20131032 (2010).","journal-title":"Eur. J. Neurol."},{"key":"BFnrneurol2011176_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s00115-010-3192-4","volume":"82","author":"C Trebst","year":"2011","unstructured":"Trebst, C. et al. Diagnosis and treatment of neuromyelitis optica: consensus recommendations of the Neuromyelitis Optica Study Group. Nervenarzt 82, 768\u2013777 (2011).","journal-title":"Nervenarzt"},{"key":"BFnrneurol2011176_CR66","first-page":"39","volume":"52","author":"JK Taylor","year":"2011","unstructured":"Taylor, J. K. & McMurray, R. V. Medical therapy for systemic lupus erythematosus. J. Miss. State Med. Assoc. 52, 39\u201343 (2011).","journal-title":"J. Miss. State Med. Assoc."},{"key":"BFnrneurol2011176_CR67","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.rmr.2010.06.011","volume":"27","author":"F Jounieaux","year":"2010","unstructured":"Jounieaux, F. et al. Infliximab treatment for chronic sarcoidosis\u2014a case series. Rev. Mal. Respir. 27, 685\u2013692 (2010).","journal-title":"Rev. Mal. Respir."},{"key":"BFnrneurol2011176_CR68","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1055\/s-0030-1262210","volume":"31","author":"DL Vargas","year":"2010","unstructured":"Vargas, D. L. & Stern, B. J. Neurosarcoidosis: diagnosis and management. Semin. Respir. Crit. Care Med. 31, 419\u2013427 (2010).","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"BFnrneurol2011176_CR69","doi-asserted-by":"publisher","first-page":"207","DOI":"10.4103\/0972-2327.70874","volume":"13","author":"S Chintamaneni","year":"2010","unstructured":"Chintamaneni, S., Patel, A. M., Pegram, S. B., Patel, H. & Roppelt, H. Dramatic response to infliximab in refractory neurosarcoidosis. Ann. Indian Acad. Neurol. 13, 207\u2013210 (2010).","journal-title":"Ann. Indian Acad. Neurol."},{"key":"BFnrneurol2011176_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jns.2008.05.002","volume":"272","author":"H Kikuchi","year":"2008","unstructured":"Kikuchi, H., Aramaki, K. & Hirohata, S. Effect of infliximab in progressive neuro-Beh\u00e7et's syndrome. J. Neurol. Sci. 272, 99\u2013105 (2008).","journal-title":"J. Neurol. Sci."},{"key":"BFnrneurol2011176_CR71","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00415-008-0061-1","volume":"255","author":"H Wiendl","year":"2008","unstructured":"Wiendl, H. et al. Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations. J. Neurol. 255, 1449\u20131463 (2008).","journal-title":"J. Neurol."},{"key":"BFnrneurol2011176_CR72","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman, C. H. et al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N. Engl. J. Med. 354, 899\u2013910 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2011176_CR73","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos, L. et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387\u2013401 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFnrneurol2011176_CR74","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00330-002-1608-7","volume":"13","author":"A Bernaerts","year":"2003","unstructured":"Bernaerts, A. et al. Tuberculosis of the central nervous system: overview of neuroradiological findings. Eur. Radiol. 13, 1876\u20131890 (2003).","journal-title":"Eur. Radiol."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T15:08:07Z","timestamp":1741878487000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,1]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["BFnrneurol2011176"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2011.176","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,1]]}}}